Excipients

Pharmaceutical excipients, which can be functional or inactive ingredients, work to enhance the medically relevant properties of the API. When used to promote ingredient qualities, excipients can be an asset for formulators to increase stability, bulk up the formulation, or enhance the therapeutic effects of the API. Below you can explore helpful resources including editorial coverage and webinars related to pharmaceutical excipients.

  • Otic Drug Delivery Systems: An Overview

    Humans have five basic senses – sight, touch, hearing, smell and taste and there is a sensory organ associated with each. Thus, hearing is one of vital senses and the ear is a vital sensory organ. read more
  • COVID-19 Five Years Later: The Impact on Drug Discovery

    Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis that has claimed more than seven million lives and whose impact continues to resonate today. Initial containment efforts for the evasive and evolving SARS-CoV-2 virus required unprecedented collaboration between nations, healthcare agencies, ... read more
  • The Overexposure to Steroids for Asthma Patients

    The Global Initiative for Asthma (GINA), an organization working to reduce asthma prevalence, morbidity, and mortality worldwide, estimates that 334 million people are directly affected by the disease, 13 million of which have severe, uncontrolled asthma, despite attempts at treatment optimization. read more
  • Novel Bioelectronic Medicine for Rheumatoid Arthritis: A Review

    Arthritis is a common medical condition that affects millions of people worldwide. It is characterized by joint inflammation, pain, stiffness and swelling which can lead to reduced mobility and quality of life. There are several treatment options available that can help to manage symptoms and improve overall quality of life. Non-Steroidal Anti-... read more
  • An Interview with Lamin Jallow

    The main difference is the level of detail in the new USP 73. As a chapter with a two-digit number, it contains some methodology and details that were missing in the original publication. For instance, it contains an equation to calculate the incubation time before ATP bioluminescence detection is performed. read more
  • Digital Clinical Trial Success Persuades CAUTION to be Replaced by ADOPTION

    In clinical research, there is no such thing as ‘taking a leap of faith’ and yet the industry’s need for empirical certainty can sometimes thwart adoption of important innovation. Understandably, the life sciences industry traditionally only takes incremental, calculated chances based on scientific hypotheses, slowing progress while patients – on ... read more
Page
Page

Webinars

  • <<
  • >>